• Thurs news: Novo Nordisk’s port strike distribution plan. Arcus/AZ renal cancer trial. Lilly weight loss drugs no longer in shortage. Difficulties of a CVS breakup. Google and Biontech AI lab assistants. See more on our front page

Zemplar has left the building









































Belviq

I will be interviewing for a rep position promoting Belviq. I would be so appreciative to receive your opinion about the organization and this new drugs position in the marketplace.

Thanks so much !
 




That Zemplar DM in Cali is the most abusive, condescending and disparaging DM I have seen in 20 years at Abbott. I hope Abbvie can see that his militaristic style only intimidates the people he needs to be empowering. He has destroyed numerous careers of very capable and successful reps. Check his HR file. Scary.


Where did he go?